Merck to seek emergency US approval of
oral COVID treatment
New York Post,
by
Will Feuer
Original Article
Posted By: Hermoine,
10/1/2021 9:05:36 AM
Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Friday that it plans to apply for emergency approval of its oral antiviral treatment for COVID-19 after the experimental drug showed “compelling results” in clinical trials.
The pill, called molnupiravir, cut the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50 percent in a late-stage trial, the companies said.
Reply 1 - Posted by:
Nashman 10/1/2021 9:11:25 AM (No. 931897)
Yep. Merckavectin. They developed it “quickly”? Right. I pray these people all go to jail.
18 people like this.
Reply 2 - Posted by:
Rokkitt 10/1/2021 9:27:03 AM (No. 931912)
Ivermectin is available as a generic drug. The patent ran out decades ago and is widely available and cheap. This new one will be patented and cost twenty or thirty times the amount of money. All paid for by the government the tax payers. Follow the money. It's the same formulation.
23 people like this.
Reply 3 - Posted by:
jimincalif 10/1/2021 10:20:44 AM (No. 931985)
Sounds like they had to dumb down ivermectin, which has better results in India than this “new” drug.
15 people like this.
Reply 4 - Posted by:
DVC 10/1/2021 11:36:15 AM (No. 932073)
Almost as good as ivermectin....but FAR more profitable.
11 people like this.
Not taking this slop, either. I don't trust any of them where the Controlvirus is concerned.
4 people like this.
Reply 6 - Posted by:
harleynyc 10/1/2021 12:10:47 PM (No. 932102)
I do not trust this or any other government pushed 'covid' lethal meds. It seems to me they're replacing us with illiterate illegal low wage grunt workers
7 people like this.
Reply 7 - Posted by:
proactus 10/1/2021 1:34:32 PM (No. 932202)
It’s a Covid treatment, and a dessert topping!
3 people like this.
Reply 8 - Posted by:
Redwing57 10/1/2021 2:07:24 PM (No. 932232)
This is interesting. An "adverse event" is any "untoward medical occurence" following this therapy, for up to seven months. And yet for the vaccines, they don't want to consider any data from the VAERS vaccine incidents - not proven to be causal, nothing to see here!
From the Merck clinical trial application:
Primary Outcome Measures :
1) Percentage of participants who are hospitalized and/or die [ Time Frame: Up to 29 days ]
Hospitalization (all cause) is ≥24 hours of acute care in a hospital or similar acute care facility. Death is due to any cause.
2) Percentage of participants with an adverse event (AE) [ Time Frame: Up to ~7 months ]
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.
3) Percentage of participants who discontinued study intervention due to an AE [Time Frame: Up to 6 days ]
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.
0 people like this.
FDA will NEVER approve this, regardless of how much Merck pays them under the table.
Why? Because it's a TREATMENT. Our overlords ban all TREATMENTS of covid (HCQ, Ivermectin, Z-Pac,...) because then you could treat covid like most any other disease. Just go to your doctor, get prescriptions, take them, and get well. The hospital is only there for backup in case of problems.
The key thing for "Biden", Fauci, etc. is POWER - power they get because of FEAR whipped up by themselves and the MSM. As long as you're afraid, you're not gonna care about silly things like Constitutions! (/sarc)
2 people like this.
Reply 10 - Posted by:
dickiedeeb 10/1/2021 11:37:32 PM (No. 932592)
Merckavectin hahaha i love it They know they dont even have to try to hide the corruption anymore theyre immune! Fauci will never be hanged so better get in on this! Its what is keeping wall st afloat! Monetized real estate equities and the... Coronahoax!
1 person likes this.
Below, you will find ...
Most Recent Articles posted by "Hermoine"
and
Most Active Articles (last 48 hours)
Comments:
Well, I guess it was time for Merck to get in (cash in) on the COVID action. Since the article does not tell us how the new drug works, I'm going to assume they have repackaged Ivermectin and adjusted the costs accordingly.